Opal Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Opal Wealth Advisors's PFE Position: Q1 2026 in Review
Opal Wealth Advisors increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $26.3K and bringing the position to 9,957 shares worth $280K. The position accounts for 0.06% of the portfolio, ranked #157.
Opal Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $566K in Q2 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Opal Wealth Advisors held 9,957 shares of Pfizer worth $280K as of Q1 2026.
- Opal Wealth Advisors bought 986 Pfizer shares in Q1 2026, an estimated $26.3K.
- Pfizer made up 0.06% of Opal Wealth Advisors's portfolio in Q1 2026, its #157 holding.
- Opal Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Opal Wealth Advisors's Pfizer position peaked at $566K in Q2 2023.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.